News Update: FDA approves drugs for prevention of cervical cancer, genital warts, and seasonal influenza

Article

The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine.

The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine. The agency also approved a new indication for the vaccine Gardasil; the agent can now be used for the prevention of genital warts caused by human papillomavirus (HPV) in boys and men aged 9 to 26 years.

Related Videos
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
Jonathan Miller, MD
Related Content
First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs | Image Credit: © Calin - © Calin - stock.adobe.com.

First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs

April 23rd 2024
Article

The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

RSV monoclonal antibody nirsevimab to be 5% more expensive | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

RSV monoclonal antibody nirsevimab to be 5% more expensive

April 15th 2024
Article

The monoclonal antibody was approved by the FDA on July 17, 2023 and quickly saw high demand at the onset of the RSV season.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

This is Serious: The results from a Measles outbreak have harmful outcomes | Image Credit: © Prostock-studio - © Prostock-studio - stock.adobe.com.

This is serious: The results of a measles outbreak have harmful outcomes

March 26th 2024
Article

Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics.

Influenza, RSV, and COVID-19: Identifying determinants of hospitalization influence | Image Credit: © angellodeco - © angellodeco- stock.adobe.com.

Influenza, RSV, and COVID-19: Identifying determinants of hospitalization influence

March 22nd 2024
Article

The investigators concluded that age-related risk differences "highlight the necessity for tailored strategies, improving understanding of and treatment development for RVIs."

© 2024 MJH Life Sciences

All rights reserved.